2002Chineae Journal of Organ TransplantationRequires access

The protective mechanism of anisodamine on liver ischemia-reperfusion injury in rats

Ping Wang

Open publisher page 0 citations

Abstract

Objective To study the protective mechanism of anisodamine on liver ischemia-reperfusion injury in rats.Methods One hundreds and sixty male Wistar rats were randomly divided into the normal control group (n=10), ischemia-reperfusion group (n=50), physiologic saline group (n=50)and anisodamine group (n=50). The animals were killed at 1st,3rd, 6th,12th,24th h after ischemia induced for 60 min and followed by reperfusion. Plasma and(or) liver endothelin-1 (ET-1), hyaluronic acid (HA), glutamic-pyruvic transaminase enzyme (ALT) and malondialdehyde (MDA) were measured. Liver intracellular i and adenosine triphosphate (ATP) after being reperfused for 1 h were measured. Meanwhile, the histopathologic hepatic alterations were also observed.Results Plasma ET-1, HA, ALT and liver ET-1, MDA, intracellular i concentrations were markedly increased and liver ATP markedly decreased after liver ischemia-reperfusion. It was found that an intravenous injection of anisodamine (2.0 mg/kg) before ischemia-reperfusion could significantly decrease the levels of HA, ALT, MDA, intracellular i and increase ATP concentrations in plasma and(or) liver. Meanwhile, the histopathologic hepatic alterations were significantly lessened.Conclusions The anisodamine have protective effects on liver ischemia-reperfusion injury.

About this research paper

What this paper is about

Objective To study the protective mechanism of anisodamine on liver ischemia-reperfusion injury in rats.Methods One hundreds and sixty male Wistar rats were randomly divided into the normal control group (n=10), ischemia-reperfusion group (n=50), physiologic saline group (n=50)and anisodamine group (n=50). The animals were killed at 1st,3rd, 6th,12th,24th h after ischemia induced for 60 min and followed by reperfusion. Plasma and(or) liver endothelin-1 (ET-1), hyaluronic acid (HA), glutamic-pyruvic transaminase enzyme (ALT) and malondialdehyde (MDA) were measured. Liver intracellular i and adenosine triphosphate (ATP) after being reperfused for 1 h were measured. Meanwhile, the histopathologic hepatic alterations were also observed.Results Plasma ET-1, HA, ALT and liver ET-1, MDA, intracellular i concentrations were markedly increased and liver ATP markedly decreased after liver ischemia-reperfusion. It was found that an intravenous injection of anisodamine (2.0 mg/kg) before ischemia-reperfusion could significantly decrease the levels of HA, ALT, MDA, intracellular i and increase ATP concentrations in plasma and(or) liver. Meanwhile, the histopathologic hepatic alterations were significantly lessened.Conclusions The anisodamine have protective effects on liver ischemia-reperfusion injury.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the protective mechanism of anisodamine on liver ischemia-reperfusion injury in rats.Methods One hundreds and sixty male Wistar rats were randomly divided into the normal control group (n=10), ischemia-reperfusion group (n=50), physiologic saline group (n=50)and anisodamine group (n=50). The animals were killed at 1st,3rd, 6th,12th,24th h after ischemia induced for 60 min and followed by reperfusion. Plasma and(or) liver endothelin-1 (ET-1), hyaluronic acid (HA), glutamic-pyruvic transaminase enzyme (ALT) and malondialdehyde (MDA) were measured. Liver intracellular i and adenosine triphosphate (ATP) after being reperfused for 1 h were measured. Meanwhile, the histopathologic hepatic alterations were also observed.Results Plasma ET-1, HA, ALT and liver ET-1, MDA, intracellular i concentrations were markedly increased and liver ATP markedly decreased after liver ischemia-reperfusion. It was found that an intravenous injection of anisodamine (2.0 mg/kg) before ischemia-reperfusion could significantly decrease the levels of HA, ALT, MDA, intracellular i and increase ATP concentrations in plasma and(or) liver. Meanwhile, the histopathologic hepatic alterations were significantly lessened.Conclusions The anisodamine have protective effects on liver ischemia-reperfusion injury.

Key concepts: Anisodamine, Ischemia, Malondialdehyde, Reperfusion injury, Medicine, Intracellular, Internal medicine, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
The protective mechanism of anisodamine on liver ischemia-reperfusion injury in rats — Research Paper | ScholarLens